Streetbeat News

Stock Prices

SPCB

SuperCom's stock is trading higher following the report of improved Q3 adjusted EPS and revenue results that surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 7:08 pm

VTGN

Stifel initiated coverage on Vistagen Therapeutics Inc (VTGN) with a Buy rating and a $12 price target, citing the potential of its lead asset, fasedienol, for social anxiety disorder. Despite a mixed outcome in previous studies, success in upcoming trials could support a marketing application. VTGN's valuation is seen as undervalued for a phase 3 CNS asset, with a current market cap around $60 million. VTGN shares rose 16.90% to $3.19.

Portfolio Pulse from Vandana Singh

November 14, 2023 | 7:08 pm

BTAI

BioXcel Therapeutics' stock price has declined following the announcement of their Q3 financial results, which were below market expectations.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 7:07 pm

BCDA

LICY

SKIN

XAIR

Beyond Air, Inc. (XAIR) shares dropped by 37.3% to $1.2701 due to weaker than expected quarterly results, with a loss of 51 cents per share and sales of $239,000 against expectations of $480,000. Other stocks experienced significant movements in Tuesday's mid-day session, with notable gainers including BioCardia, Inc. (BCDA), reAlpha Tech Corp. (AIRE), and Theseus Pharmaceuticals, Inc. (THRX), among others. Losers included Li-Cycle Holdings Corp. (LICY) and The Beauty Health Company (SKIN), which both saw sharp declines after reporting disappointing financial results.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 7:05 pm

NVO

Belgium has temporarily banned the use of Novo Nordisk's Ozempic for weight loss due to a medication shortage. Ozempic, primarily for Type 2 diabetes, has been used off-label for weight loss, increasing demand. The ban aims to preserve supplies for diabetic patients, with restricted availability expected until June 2024. Novo Nordisk is investing to increase supply, with a recent $6 billion investment to expand manufacturing in Denmark. NVO shares dropped 1.55% following the news.

Portfolio Pulse from Vandana Singh

November 14, 2023 | 7:05 pm

HYZN

Hyzon Motors Inc (NASDAQ:HYZN) shares surged after reporting Q3 FY23 results. Despite a wider net loss of $(41.1) million and a loss per share of $(0.18), exceeding consensus estimates, the company showed progress by delivering its first revenue-generating FCEV in North America and deploying 14 FCEVs under commercial agreements. Operational efficiencies led to the lowest cash burn in eight quarters. The company also resolved an SEC investigation with a $25 million penalty and appointed a new CFO, Stephen Weiland. HYZN's stock rose 35.75% to $1.07.

Portfolio Pulse from Lekha Gupta

November 14, 2023 | 7:05 pm

RNLX

Renalytix reported a year-over-year decrease in Q1 sales results, leading to a decline in its stock price.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 7:04 pm

EL

Estee Lauder Cos Inc. (NYSE:EL) saw a 1.89% increase in its stock price to $115.88 in the current market session, despite a 13.53% decrease over the past month and a 44.66% drop over the past year. The company's P/E ratio of 74.33 is significantly higher than the Personal Products industry average of 30.47, which could suggest that investors expect better future performance or that the stock is overvalued.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 7:02 pm

INVO

INVO BioScience shares have seen an uptick following the announcement of improved year-over-year financial results for Q3.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 7:01 pm

TW

Tradeweb Markets (NASDAQ:TW) has received updated analyst ratings in the last quarter, with 3 bullish, 5 somewhat bullish, and 2 indifferent ratings. The average 12-month price target among 10 analysts is $96.3, with a high of $109.00 and a low of $81.00. This target reflects a 7.12% increase over the past month. Analyst ratings are based on future earnings predictions and company risk assessments, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 7:00 pm